Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder

Neuroscience and Biobehavioral Reviews

Volumn 24, Issue 1, 2000, Pages 51-57

  Wilson, Michael C ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

ADHD; Ampethamine; Coloboma; Dopamine; Genetic complementation; Hyperkinesis; Mouse mutant; Nigra striatal pathway; Pair pulse inhibition; SNAP 25; Striatum

Indexed keywords

CALCIUM ION; DEXAMPHETAMINE; DOPAMINE; SYNAPTOBREVIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN;

ANIMAL MODEL; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; COLOBOMA; CONFERENCE PAPER; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; ELECTROPHYSIOLOGY; EYE DISEASE; GENE DELETION; GENETIC DISORDER; HIPPOCAMPUS; HYPERACTIVITY; HYPERKINESIA; LEARNING DISORDER; MOUSE; MUTANT; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; TRANSGENE;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COLOBOMA; HYPERKINESIS; MICE; MICE, NEUROLOGIC MUTANTS;

EID: 0033962487     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(99)00064-0     Document Type: Conference Paper

References (38)

1. Szatmari P. The epidemiology of attention deficit hyperactivity disorder. Child Adolesc Psychiat Clin North Am. 1:1992;361-371.
2. Gittleman R., Mannuzza S., Shenker R., Bonagura N. Hyperactive boys almost grown up, I: psychiatric status. Arch Gen Psychiat. 42:1985;937-947.
3. Mannuzza S., Klein R.G., Bessler A., Malloy P., LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank and psychiatric status. Arch Gen Psychiat. 50:1993;565-576.
4. Faraone S.V., Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psych. 44:1998;951-958.
5. Castellanos F.X., Elia J., Kruesi M.J., Marsh W.L., Gulotta C.S., Potter W.Z., Ritchie G.F., Hamburger S.D., Rapoport J.L. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Neuropsychopharmacology. 14:1996;125-137.
6. Castellanos F.X., Giedd J.N., Hamburger S.D., Vaituzis A.C., Dickstein D.P., Sarfatti S.E., Vaus Y.C., Snell J.W., Rajapakse J.C., Rapoport J.L. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psych. 53:1996;607-616.
7. Barkley R.A. Attention-deficit/hyperactivity disorder, self-regulation, and time: toward a more comprehensive theory. Dev Behav Pediatrics. 18:1997;271-279.
8. Tharpar A. Attention deficit disorder: unraveling the molecular genetics. Mol Psychiat. 3:1998;370-372.
9. Castellanos F.X., Lau E., Tayebi N., Lee P., Long R.E., Giedd J.N., Sharp W., Marsh W.L., Walter J.M., Hamburger S.D., Ginns E.I., Rapoport J.L., Sidransky E. Lack of an association between a dopamine-4 receptor polymorphism and attention deficit hyperactivity disorder: genetic and brain polymorphic analyses. Mol Psychiat. 3:1998;431-434.
10. Sagvolden T., Pettersen M.B., Larsen M.C. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol Behav. 54:1993;1047-1055.
11. Cerbone A., Patacchioli F.R., Sadile A.G. A neurogenetic and morphological approach to hippocampal functions based on individual differences and neurobehavioral covariations. Behav Brain Res. 55:1993;1-16.
12. Kostrzewa R.M., Brus R., Kalbfleisch J.H., Perry K.W., Fuller R.W. Proposed model of attention deficit hyperactivity disorder. Brain Res Bull. 1994;161-167.
13. Russell V., De Villiers A., Sagvolden T., Lamm M., Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Brain Res. 676:1995;343-351.
14. Russell V., De Villiers A., Sagvolden T., Lamm M., Taljaard J. Differences between electrically-, ritalin- and D-amphtamine-stimulated release of [3H] dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res. 94:1998;163-171.
15. Theiler K., Varnum D.S. Development of Coloboma (Cm/+), a mutation with anterior lens adhesion. Anat Embryol. 162:1981;121-126.
16. Searle A.G. New mutants 2: Coloboma. Mouse News Lett. 35:1966;27.
17. Hess E.J., Collins K.A., Wilson M.C. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J Neurosci. 16:1996;3104-3111.
18. Raber J., Mehta P.P., Kreifeldt M., Parsons L.H., Weiss F., Bloom F.E., Wilson M.C. Coloboma hyperactivie mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. J Neurochem. 68:1997;176-186.
19. Heyser C.J., Wilson M.C., Gold L.H. Coloboma hyperactive mouse mutant exhibits delayed neurobehavioral developmental milestones. Dev Brain Res. 89:1995;264-269.
20. Snell G.D., Bunker H.P. Coloboma linkage. Mouse News Lett. 37:1967;34.
21. Davisson M.T., Lewis S.E. Chromosomal aberrations associated with induced mutations: effect on mapping new mutations. Allen J.W. Branbury Report. 1990;195-206 Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
22. Hess E.J., Collins K.A., Copeland G., Jenkins N.A., Wilson M.C. Deletion map of the coloboma (Cm) locus on mouse chromosome 2. Genomics. 21:1994;257-261.
23. Oda T., Elkahloun A.G., Pike B.L., Okajama K., Krantz I.D., Genin A., Piccoli D.A., Meltzer P.S., Spinner N.B., Collins F.S., Chandrasekharappa S.C. Mutations in the human Jagged 1 gene are responsible for Alagille Syndrome. Nature Genet. 16:1997;235-242.
24. Li L., Krantz I.O., Deng Y., Genin A., Bantz A.B., Collins C.C., Qi M., Trask B.J., Kuo W.L., Cochran J., Costa T., Pierpont M.E., Rand E.B., Piccoli D.A., Hood L., Spinner N.B. Alagille Syndrome is caused by mutations in human Jagged 1 which encodes a ligand for Notch 1. Nature Genet. 16:1997;243-251.
25. Hess E.J., Jinnah H.A., Kozak C.A., Wilson M.C. Spontaneous locomotor hyperactivity in the mouse induced by a deletion including the Snap gene on Chromosome 2. J Neurosci. 12:1992;2865-2874.
26. Chapman E.R., An S., Barton N., Jahn R. SNAP-25, a t-SNARE which binds to both syntaxin and synaptobrevin via domains that may form coiled coils. J Biol Chem. 269:1994;27 427-27 432.
27. Bark I.C., Wilson M.C. Regulated vesicular fusion in neurons - snapping together the details. Proc Natl Acad Sci USA. 91:1994;4621-4624.
28. Calakos N., Scheller R.H. Synaptic vesicle biogenesis, docking, and fusion: a molecular description. Physiol Rev. 76:1996;1-29.
29. Sudhof T.C. Synaptic vesicle cycle: a cascade of protein-protein interactions. Nature. 375:1995;645-653.
30. Weber T., Zemelman B.V., McNew J.A., Westermann B., Gmachl M., Parlati F., Sollner T.H., Rothman J.E. SNAREpins: minimal machinery for membrane fusion. Cell. 92:1998;759-772.
31. Montecucco C., Schiavo G. Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol. 13:1994;1-8.
32. Steffensen S.C., Wilson M.C., Henriksen S.J. Coloboma contiquous gene deletion encompassing snap alters hippocampal plasticity. Synapse. 22:1996;281-289.
33. Morgenson G.J. Limbic-motor integration. Progress. 12:1987;117-170.
34. Henriksen S.J., Criado J.R., Steffensen S.C. Atropine-resistant hippocampal theta is mediated by dopamine. Soc Neurosci Abst. 20:1994;801.
35. Sulzer D., Chen T.K., Lau Y.Y., Kristensen H., Rayport S., Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytol, and promotes reverses transport. J Neurosci. 15:1995;4102-4108.
36. Barkley R.A. A review of stimulant drug research in hyperactive children. J Child Psychol Psychiat. 18:1977;137-165.
37. Elia J., Borcherding B.G., Rapoport J.L., Keysor C.S. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders. Psychiat Res. 36:1991;141-155.
38. Steffensen SC, Henriksen SJ, Wilson MC. Transgenic rescue of SNAP-25 restores dopamine-modulated synaptic transmission in the coloboma mutant. Brain Res, in press.